Pain Therapeutics (PTIE) Gains on FDA Nod

Pain Therapeutics, Inc. (NASDAQ: PTIE) rose 5.7% to $2.22 on news the FDA had accepted REMOXY’s New Drug Application (NDA) for review, setting a PDUFA date of September 25. Share volume was 240,000, compared to an all-day average of 85,000